International Biotechnology (LON:IBT) Shares Cross Above Two Hundred Day Moving Average – Here’s Why

International Biotechnology (LON:IBT)’s stock price passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 980.60 and traded as high as GBX 1,094.25. International Biotechnology shares last traded at GBX 1,090, with a volume of 34,758 shares changing hands.

International Biotechnology Trading Down 0.9%

The company has a debt-to-equity ratio of 9.43, a current ratio of 0.11 and a quick ratio of 0.32. The firm has a market capitalization of £341.88 million, a price-to-earnings ratio of 4.45 and a beta of 0.47. The business’s 50-day moving average price is GBX 1,060.10 and its 200 day moving average price is GBX 981.41.

International Biotechnology (LON:IBT) last announced its earnings results on Tuesday, May 12th. The company reported GBX (4.83) earnings per share for the quarter. The business had revenue of GBX 24 million for the quarter. International Biotechnology had a net margin of 82.27% and a return on equity of 27.35%. On average, equities analysts forecast that International Biotechnology will post 0.9435943 earnings per share for the current fiscal year.

About International Biotechnology

The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.

The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology. Investments may also be made in related sectors such as medical devices and healthcare services.